Search alternatives:
predicted decrease » predicted secreted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
predicted decrease » predicted secreted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
-
81
-
82
-
83
-
84
DataSheet_1_Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antir...
Published 2022“…More importantly, in the present cohort, a higher level of sCD73 at the time of initiating ART could predict poor immune reconstitution in PLWH after long-term ART. …”
-
85
-
86
-
87
Data_Sheet_1_Early decrease of ventilatory ratio after prone position ventilation may predict successful weaning in patients with acute respiratory distress syndrome: A retrospecti...
Published 2022“…</p>Conclusion<p>Ventilatory ratio decreased more significantly within 4 h after prone positioning in patients with successful weaning at day 28. …”
-
88
-
89
-
90
Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report
Published 2024“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
-
91
-
92
-
93
-
94
-
95
-
96
Estimated annual variation in predicted skin lesion point prevalence by pod.
Published 2023Subjects: -
97
-
98
-
99
-
100